Microsomal and peroxisomal fatty acid oxidation in streptozotocin diabetic rat liver
Author
dc.contributor.author
Orellana, Myriam
Author
dc.contributor.author
Valdés, Elena
Author
dc.contributor.author
Del Villar, Eugenia
Admission date
dc.date.accessioned
2018-12-20T14:32:18Z
Available date
dc.date.available
2018-12-20T14:32:18Z
Publication date
dc.date.issued
1997
Cita de ítem
dc.identifier.citation
General Pharmacology, Volumen 28, Issue 3, 2018, Pages 361-364
Identifier
dc.identifier.issn
03063623
Identifier
dc.identifier.other
10.1016/S0306-3623(96)00231-5
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/156340
Abstract
dc.description.abstract
Microsomal lauric acid hydroxylation and fatty acid peroxisomal β-oxidation were studied in hepatic subcellulant preparations from streptozotocin-induced diabetic and diabetic insulin-treated rats. The liver microsomes of the streptozotocin diabetic rats displayed a similar activity to hydroxylate lauric acid as the control microsomes. Diabetic insulin-treated rats showed lower (ω1) and ω-lauric acid hydroxylase activities than diabetic and control rats. Streptozotocin-induced diabetes and diabetic insulin-treated rats exhibited no significant changes on peroxisomal palmitoyl CoA β-oxidation compared to the control rats. Both microsomal and peroxisomal fatty acid oxidation responded in a similar way in this model of experimental diabetes.